Pinnacle Medicines
PrivateLast Round
Series B
Mar 26, 2026
Total Funding Raised
$179M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Pinnacle Medicines is a biotechnology company that develops oral peptide therapeutics designed to deliver biologic-level efficacy with the convenience of oral dosing for immunology and cardiometabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pinnacle Medicines Comparables
Compare Pinnacle Medicines with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Unnatural Products | 82% | |
| Vilya | 81% | |
| Orbis Medicines | 78% | |
Pinnacle Medicines Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 26, 2026 |
Pinnacle Medicines Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Series B |
| OrbiMed | Series B, Series A |
| Logos Capital | Series B |
| Foresite Capital | Series B |
| Lilly Asia Ventures | Series B |
| Hankang Capital | Series B |
| Qiming Venture Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 22, 2026
Open roles increased to 4, 4x the trailing average.
- Jun 2, 2026
Grew 24% QoQ from 17 to 21 employees.
Pinnacle Medicines Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Pinnacle Medicines's valuation, stock price, and market status.